 |
| |  |
| | | |
| FACULTY BIOGRAPHY |
|
| <-- Back
|
| Alan McEmber |
| Lecturer |
|
|
|
Alan McEmber has been employed in pharmaceutical development since 1984, in the areas of regulatory affairs and clinical research. He has US and international (Canada, EU, Japan, Australia) regulatory product development experience with drugs, biologics, devices, and combination products. Responsibilities have included providing regulatory strategy throughout the product life-cycle, beginning in discovery and product development, through clinical investigation, and market authorization. Responsibilities have also included development, submission, and management of documentation in support of clinical investigational and marketing approval applications.
Alan is currently Director and Regulatory Lead – Worldwide Regulatory Strategy for Pfizer Inc. Prior to joining Pfizer, he was employed by Alexion Pharmaceuticals, as Director, Quality Assurance & Regulatory Affairs. He has also held regulatory positions with Boehringer-Ingelheim Pharmaceuticals, Parke Davis Pharmaceutical Research, and regulatory/clinical positions with 3M Health Care/3M Pharmaceuticals.
Alan has a B.S. degree in Microbiology from the University of Michigan and holds a M.S. in Environmental Health (occupational health) from the University of Minnesota. Alan holds Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS).
|
|
| |
| | |
|
|
